<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Lasa Supergenerics Ltd. — News on 6ix</title>
<link>https://6ix.com/company/lasa-supergenerics-limited</link>
<description>Latest news and press releases for Lasa Supergenerics Ltd. on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Thu, 24 Apr 2025 21:30:09 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/lasa-supergenerics-limited" rel="self" type="application/rss+xml" />
<image>
<url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo68364dce78dffbe2df154440.webp</url>
<title>Lasa Supergenerics Ltd.</title>
<link>https://6ix.com/company/lasa-supergenerics-limited</link>
</image>
<item>
<title>Press Release Apr 24 2025</title>
<link>https://6ix.com/company/lasa-supergenerics-limited/news/press-release-apr-24-2025-30</link>
<guid isPermaLink="true">https://6ix.com/company/lasa-supergenerics-limited/news/press-release-apr-24-2025-30</guid>
<pubDate>Thu, 24 Apr 2025 21:30:09 GMT</pubDate>
<description>Lasa Supergenerics Limited has informed the Exchange regarding a press release dated April 24, 2025, titled "Press Release titled Lasa Supergenerics Limited Announces the Expansion of Manufacturing Capacity of API Albendazole to meet the Growing Demands issued by the Company. ".</description>
</item>
<item>
<title>Press Release Nov 13 2024</title>
<link>https://6ix.com/company/lasa-supergenerics-limited/news/press-release-nov-13-2024-29</link>
<guid isPermaLink="true">https://6ix.com/company/lasa-supergenerics-limited/news/press-release-nov-13-2024-29</guid>
<pubDate>Wed, 13 Nov 2024 22:51:57 GMT</pubDate>
<description>Lasa Supergenerics Limited has informed the Exchange regarding a press release dated November 13, 2024, titled " SUCCESSFUL WITHDRAWAL OF APPLICATION UNDER SECTION 7 OF I&B, 2016 FILED AGAINST THE COMPANY BY FINANCIAL CREDITOR ".</description>
</item>
<item>
<title>Press Release Apr 26 2022</title>
<link>https://6ix.com/company/lasa-supergenerics-limited/news/press-release-apr-26-2022-13</link>
<guid isPermaLink="true">https://6ix.com/company/lasa-supergenerics-limited/news/press-release-apr-26-2022-13</guid>
<pubDate>Tue, 26 Apr 2022 21:59:55 GMT</pubDate>
<description>Lasa Supergenerics Limited has informed the Exchange about press release dated 26-Apr-2022 titled ���LASA SECURES BULK ORDER OF ��� 500 MILLION</description>
</item>
<item>
<title>Press Release Apr 11 2022</title>
<link>https://6ix.com/company/lasa-supergenerics-limited/news/press-release-apr-11-2022-9</link>
<guid isPermaLink="true">https://6ix.com/company/lasa-supergenerics-limited/news/press-release-apr-11-2022-9</guid>
<pubDate>Mon, 11 Apr 2022 19:20:42 GMT</pubDate>
<description>Lasa Supergenerics Limited has informed the Exchange about press release dated 11-Apr-2022 titled LASA SUPERGENERICS PAT AT 12.35 Cr up by Robust 362% as compared to Loss of 4.71 Cr in Q3FY22</description>
</item>
<item>
<title>Press Release Mar 09 2022</title>
<link>https://6ix.com/company/lasa-supergenerics-limited/news/press-release-mar-09-2022-9</link>
<guid isPermaLink="true">https://6ix.com/company/lasa-supergenerics-limited/news/press-release-mar-09-2022-9</guid>
<pubDate>Thu, 10 Mar 2022 01:10:30 GMT</pubDate>
<description>Lasa Supergenerics Limited has informed the Exchange about press release dated 09-Mar-2022 titled ���LASA FILES ANOTHER SUIT FOR PERMANENT INJUNCTION AGAINST ONE OF ITS COMPETITOR��� issued by the Company.</description>
</item>
<item>
<title>Press Release Dec 16 2021</title>
<link>https://6ix.com/company/lasa-supergenerics-limited/news/press-release-dec-16-2021-18</link>
<guid isPermaLink="true">https://6ix.com/company/lasa-supergenerics-limited/news/press-release-dec-16-2021-18</guid>
<pubDate>Thu, 16 Dec 2021 14:17:36 GMT</pubDate>
<description>Lasa Supergenerics Limited has informed the Exchange regarding a press release dated December 16, 2021, titled "Hon ble High Court of Judicature at Bombay ordered Closure dated 06.10.2021 of MPCB shall not be acted on and it shall be treated as show cause Notice ".</description>
</item>
<item>
<title>Press Release Aug 23 2021</title>
<link>https://6ix.com/company/lasa-supergenerics-limited/news/press-release-aug-23-2021-6</link>
<guid isPermaLink="true">https://6ix.com/company/lasa-supergenerics-limited/news/press-release-aug-23-2021-6</guid>
<pubDate>Mon, 23 Aug 2021 17:38:28 GMT</pubDate>
<description>Lasa Supergenerics Limited has informed the Exchange regarding a press release dated August 23, 2021, titled "Attached is a copy of Press Release tilted LASA SUPERGENERICS RESUMES OPERATIONS IN ALLUNITS SITUATED IN MAHAD AND CHIPLUN. Issued by the company.".</description>
</item>
<item>
<title>Press Release Jul 26 2021</title>
<link>https://6ix.com/company/lasa-supergenerics-limited/news/press-release-jul-26-2021-12</link>
<guid isPermaLink="true">https://6ix.com/company/lasa-supergenerics-limited/news/press-release-jul-26-2021-12</guid>
<pubDate>Mon, 26 Jul 2021 19:02:25 GMT</pubDate>
<description>Lasa Supergenerics Limited has informed the Exchange regarding a press release dated July 26, 2021, titled "Attached is a copy of Press Release tilted No Casualty in any of company s units. Production to recommence in couple of Weeks. Issued by the company. ".</description>
</item>
<item>
<title>Press Release Jun 09 2021</title>
<link>https://6ix.com/company/lasa-supergenerics-limited/news/press-release-jun-09-2021-9</link>
<guid isPermaLink="true">https://6ix.com/company/lasa-supergenerics-limited/news/press-release-jun-09-2021-9</guid>
<pubDate>Wed, 09 Jun 2021 15:10:42 GMT</pubDate>
<description>Lasa Supergenerics Limited has informed the Exchange regarding a press release dated Jun 09, 2021, titled "Attached is the copy of Press Release titled LASA launches new product Oxyclozanide Creating new Capacity as a brown field expansion issued by the company.".</description>
</item>
<item>
<title>Press Release Jun 01 2021</title>
<link>https://6ix.com/company/lasa-supergenerics-limited/news/press-release-jun-01-2021-9</link>
<guid isPermaLink="true">https://6ix.com/company/lasa-supergenerics-limited/news/press-release-jun-01-2021-9</guid>
<pubDate>Wed, 02 Jun 2021 00:32:55 GMT</pubDate>
<description>Lasa Supergenerics Limited has informed the Exchange regarding a press release dated Jun 01, 2021, titled "LASA SUPERGENERICS ANNOUNCES ROBUST PAT AT 22.80CRS, UP 521% YOY, with Recommendation of Dividend".</description>
</item>
<item>
<title>Press Release Feb 02 2021</title>
<link>https://6ix.com/company/lasa-supergenerics-limited/news/press-release-feb-02-2021-18</link>
<guid isPermaLink="true">https://6ix.com/company/lasa-supergenerics-limited/news/press-release-feb-02-2021-18</guid>
<pubDate>Tue, 02 Feb 2021 18:06:55 GMT</pubDate>
<description>Lasa Supergenerics Limited has informed the Exchange regarding a press release dated February 02, 2021, titled "Attached is the copy of Press Release titled LASA SUPERGENERICS Q3FY21 PAT AT 6.56 CRSUP BY 154% YoY Finance Cost Reduced by 95.40% YoY. issued by the company".</description>
</item>
<item>
<title>Press Release Jan 12 2021</title>
<link>https://6ix.com/company/lasa-supergenerics-limited/news/press-release-jan-12-2021-4</link>
<guid isPermaLink="true">https://6ix.com/company/lasa-supergenerics-limited/news/press-release-jan-12-2021-4</guid>
<pubDate>Tue, 12 Jan 2021 17:15:45 GMT</pubDate>
<description>Lasa Supergenerics Limited has informed the Exchange regarding a press release dated January 12, 2021, titled "LASA SUPERGENERICS RECEIVED WHO Nod for its unit Located at Khed (Ratnagiri).".</description>
</item>
<item>
<title>Press Release Nov 24 2020</title>
<link>https://6ix.com/company/lasa-supergenerics-limited/news/press-release-nov-24-2020-4</link>
<guid isPermaLink="true">https://6ix.com/company/lasa-supergenerics-limited/news/press-release-nov-24-2020-4</guid>
<pubDate>Tue, 24 Nov 2020 22:54:52 GMT</pubDate>
<description>Lasa Supergenerics Limited has informed the Exchange regarding a press release dated November 24, 2020, titled "Lasa Receives further Injunction from Hon ble High Court, Bombayrestraining its competitor from Manufacturing albendazole in addition toother reliefs which is subject matter of patent infringement case, until disposal of suit.".</description>
</item>
<item>
<title>Press Release Nov 04 2020</title>
<link>https://6ix.com/company/lasa-supergenerics-limited/news/press-release-nov-04-2020-25</link>
<guid isPermaLink="true">https://6ix.com/company/lasa-supergenerics-limited/news/press-release-nov-04-2020-25</guid>
<pubDate>Wed, 04 Nov 2020 16:47:19 GMT</pubDate>
<description>Lasa Supergenerics Limited has informed the Exchange regarding a press release dated November 04, 2020, titled "Lasa Supergenerics Receives EnvironmentalClearance for Benzimidazole Derivatives Capacity Expansion in Unit 2 Located atKhed .".</description>
</item>
<item>
<title>Press Release Oct 27 2020</title>
<link>https://6ix.com/company/lasa-supergenerics-limited/news/press-release-oct-27-2020-16</link>
<guid isPermaLink="true">https://6ix.com/company/lasa-supergenerics-limited/news/press-release-oct-27-2020-16</guid>
<pubDate>Tue, 27 Oct 2020 18:40:20 GMT</pubDate>
<description>Lasa Supergenerics Limited has informed the Exchange regarding a press release dated October 26, 2020, titled "Lasa Supergenerics Reports Revenue of &#8377; 109 Crores in H1 FY21 higher by 38% YoYProfit After Tax in Q2 FY21 grew by 31% on a QoQ basis to &#8377; 7 Crores".</description>
</item>
<item>
<title>Press Release Oct 20 2020</title>
<link>https://6ix.com/company/lasa-supergenerics-limited/news/press-release-oct-20-2020-18</link>
<guid isPermaLink="true">https://6ix.com/company/lasa-supergenerics-limited/news/press-release-oct-20-2020-18</guid>
<pubDate>Wed, 21 Oct 2020 03:13:45 GMT</pubDate>
<description>Lasa Supergenerics Limited has informed the Exchange regarding a press release dated October 20, 2020, titled "Attached is a copy of Press Release tilted ex parte interim relief restraining itscompetitor from selling, offering for sale, importing, exporting, or dealing inAlbendazole issued by the company".</description>
</item>
<item>
<title>Press Release Aug 06 2020</title>
<link>https://6ix.com/company/lasa-supergenerics-limited/news/press-release-aug-06-2020-23</link>
<guid isPermaLink="true">https://6ix.com/company/lasa-supergenerics-limited/news/press-release-aug-06-2020-23</guid>
<pubDate>Thu, 06 Aug 2020 15:54:13 GMT</pubDate>
<description>Lasa Supergenerics Limited has informed the Exchange regarding a press release dated August 06, 2020, titled " LASA SUPERGENERICS Q1FY21 PAT AT 5.37CRS, UP437% YOY".</description>
</item>
</channel>
</rss>